ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.969,86
-1,44%
S&P 500
5.867,08
-0,09%
Dow Jones
42.342,24
0,04%
Euro vs US Dollar
1,03745
0,10%
Bitcoin
98.041,62
0,60%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV
  6. Cotec Holdings Corp (CTH)

  7. Cotec Holdings Corp (CTH) News

CTH

Cotec (CTH)

Cotec Holdings Corp
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:CTH
DatumZeitQuelleÜberschriftSymbolFirma
19/11/201415h35PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - CTHTSXV:CTHCotec Holdings Corp
19/11/201415h33PR Newswire (Canada)IIROC Trading Resumption - CTHTSXV:CTHCotec Holdings Corp
18/11/201422h12PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - CTHTSXV:CTHCotec Holdings Corp
18/11/201422h10PR Newswire (Canada)IIROC Trading Halt - CTHTSXV:CTHCotec Holdings Corp
17/07/201422h15Marketwired CanadaCynapsus Therapeutics Commences Phase 2 Clinical Trials in the United StatesTSXV:CTHCotec Holdings Corp
08/07/201412h00Marketwired CanadaCynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's ResearchTSXV:CTHCotec Holdings Corp
20/05/201422h42MarketwiredCynapsus Therapeutics Grants Stock OptionsTSXV:CTHCotec Holdings Corp
20/05/201422h42Marketwired CanadaCynapsus Therapeutics Grants Stock OptionsTSXV:CTHCotec Holdings Corp
14/05/201412h00MarketwiredCynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
14/05/201412h00Marketwired CanadaCynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
07/05/201423h30Marketwired CanadaCynapsus Therapeutics Reports First Quarter 2014 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
07/05/201423h30MarketwiredCynapsus Therapeutics Reports First Quarter 2014 Financial Results and Recent DevelopmentsTSXV:CTHCotec Holdings Corp
24/04/201412h00MarketwiredCynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
24/04/201412h00Marketwired CanadaCynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's DiseaseTSXV:CTHCotec Holdings Corp
15/04/201416h56PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - CTHTSXV:CTHCotec Holdings Corp
15/04/201416h56PR Newswire (Canada)IIROC Trading Resumption - CTHTSXV:CTHCotec Holdings Corp
15/04/201416h27Marketwired CanadaCynapsus Therapeutics Completes $25,000,000 Short Form Prospectus OfferingTSXV:CTHCotec Holdings Corp
15/04/201414h19PR Newswire (Canada)IIROC Trading Halt - CTHTSXV:CTHCotec Holdings Corp
15/04/201414h19PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - CTHTSXV:CTHCotec Holdings Corp
09/04/201404h14Marketwired CanadaCynapsus Therapeutics Files Final Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201421h50Marketwired CanadaCynapsus Therapeutics Files Preliminary Short Form ProspectusTSXV:CTHCotec Holdings Corp
28/03/201411h00MarketwiredCynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277TSXV:CTHCotec Holdings Corp
28/03/201411h00Marketwired CanadaCynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-130277TSXV:CTHCotec Holdings Corp
27/03/201421h00MarketwiredCynapsus Therapeutics Reports 2013 Financial Results and Highlights Key DevelopmentsTSXV:CTHCotec Holdings Corp
27/03/201421h00Marketwired CanadaCynapsus Therapeutics Reports 2013 Financial Results and Highlights Key DevelopmentsTSXV:CTHCotec Holdings Corp
27/02/201415h22MarketwiredCynapsus Therapeutics Announces DTC ApprovalTSXV:CTHCotec Holdings Corp
27/02/201414h22Marketwired CanadaCynapsus Therapeutics Announces DTC ApprovalTSXV:CTHCotec Holdings Corp
13/02/201414h00MarketwiredCynapsus Therapeutics Appoints Nan Hutchinson to the Board of DirectorsTSXV:CTHCotec Holdings Corp
13/02/201413h00Marketwired CanadaCynapsus Therapeutics Appoints Nan Hutchinson to the Board of DirectorsTSXV:CTHCotec Holdings Corp
07/02/201415h15MarketwiredLifeSci Advisors Initiates Coverage of Cynapsus Therapeutics, Inc.TSXV:CTHCotec Holdings Corp
 Showing the most relevant articles for your search:TSXV:CTH

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
TG
RHM
Rheinmetall
COIN
XRPUSD
Ripple
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
TG
DTE
Deutsche Telekom
CCOM
US100
US Tech 100
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
TG
BAS
BASF
FX
EURUSD
Euro vs US Dollar
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten